Beetroot juice may help stave off memory loss, small study hints
NCT ID NCT07329647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether drinking beetroot juice daily for two weeks can improve memory and brain blood flow in 25 people with small vessel disease and diabetes. The juice is rich in nitrate, which the body can convert to nitric oxide, a molecule that helps blood vessels widen. Researchers will compare the effects of nitrate-rich beetroot juice against a placebo juice that has the nitrate removed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- beetroot juice (dietary nitrate)
- What this could lead to
- If it works, this could point toward a simple dietary supplement to help slow memory loss in people with small vessel disease.
- What could go wrong
- This is a very small pilot study with only 25 participants, so results may not apply widely. The treatment is short-term (2 weeks), and any benefits might be small or temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Formal diagnosis of cerebral small vessel disease (grades 1 to 3 in the Age-Related White Matter Changes Scale as assessed by Computerized Tomography or Magnetic Ressonance Imaging - MRI) and patients at high risk for cerebral small vessel disease with diabetes mellitus; * Subject has capacity and is capable of giving written informed consent; * Subject is able to read, comprehend and record information written in Portuguese. Exclusion Criteria: * Vascular diseases other than cerebral Small Vessel Disease (cSVD); * Stroke event less than 6 months ago; * Unsuitable for MRI scanning because of presence of any standard MRI contraindication (e.g presence of a cardiac pacemaker, other medical implants or devices, or the presence of ferromagnetic metal foreign bodies); * Needle phobia; * Inability or intolerance to dietary polyphenol adjustment; * Current smoker; * Alcohol abuse, drug abuse or use of drugs affecting cognitive assessment, such as sedatives, hypnotics, nootropic drugs, cholinergic drugs; * Use of medications that may be contraindicated or interact with the high nitrate diet, such as nitroglycerin or nitrate preparations used for angina, or phosphodiesterase type 5 (PDE5) inhibitors, including sildenafil (Viagral); * Patients previously diagnosed with dementia; * Presence of congenital mental retardation and severe neurological and psychiatric diseases; * Illiterate or severe visual or hearing impairment that may prevent patients from cooperating with cognitive assessment; * Relevant depression or other unrelated serious mental illness; * Severe cardiac, pulmonary, renal or hepatic insufficiency; * Patients who have participated in other interventional clinical studies within the last 3 months, or are participating in other interventional clinical studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra
RECRUITINGCoimbra, Portugal
-
Unidade de Saúde Local de Coimbra (ULS Coimbra)
RECRUITINGCoimbra, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Plant-Based diet program help patients lose weight and improve heart health?
- Does diabetes leave its mark on Women's hair? scalp scans put the question under the microscope
- Turmeric nanoparticle gel put to the test against diabetic foot ulcers
- How low should cholesterol go after a small vessel stroke?
- Can a High-Protein or High-Fat Low-Carb diet tame blood sugar and triglycerides?
- Can transplanted cells restore insulin production in type 2 diabetes?